Genscript Biotech Corp Class H 01548
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover 01548, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
Trading Information
- Previous Close Price
- HK$13.88
- Day Range
- HK$12.78–14.10
- 52-Week Range
- HK$7.43–24.95
- Bid/Ask
- HK$13.54 / HK$13.56
- Market Cap
- HK$28.86 Bil
- Volume/Avg
- 8.2 Mil / 12.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 90.02
- Price/Sales
- 3.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
GenScript Biotech is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 7,284
- Website
- https://www.genscript.com
Comparables
Valuation
|
Metric
|
01548
|
301207
|
02616
|
|---|---|---|---|
Price/Earnings (Normalized) | 90.02 | 17.92 | — |
Price/Book Value | 3.37 | 2.11 | — |
Price/Sales | 3.72 | 5.45 | 5.01 |
Price/Cash Flow | — | 13.22 | — |
Price/Earnings
01548
301207
02616
Financial Strength
|
Metric
|
01548
|
301207
|
02616
|
|---|---|---|---|
Quick Ratio | 3.96 | 2.85 | 1.45 |
Current Ratio | 4.15 | 3.42 | 1.71 |
Interest Coverage | −12.77 | 149.96 | −10.14 |
Quick Ratio
01548
301207
02616
Profitability
|
Metric
|
01548
|
301207
|
02616
|
|---|---|---|---|
Return on Assets (Normalized) | −6.09% | 9.24% | −8.54% |
Return on Equity (Normalized) | −16.77% | 11.52% | — |
Return on Invested Capital (Normalized) | −11.12% | 10.82% | −17.14% |
Return on Assets
01548
301207
02616
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Txwprfnsdn | Wndyq | $518.0 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Tdqdbvrp | Mlrbnvl | $119.3 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Frrwvcrj | Lqdjnd | $114.7 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Zcgxssdq | Lbtntm | $34.9 Bil | |||
| argenx SE ADR
ARGX
| Qttckzmx | Jlhz | $32.9 Bil | |||
| BioNTech SE ADR
BNTX
| Wdglhcrp | Zhrk | $28.3 Bil | |||
| Moderna Inc
MRNA
| Pskzysbg | Xcppc | $24.3 Bil | |||
| United Therapeutics Corp
UTHR
| Kvpcmncsc | Lmnm | $15.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hncztrtms | Hpnmt | $13.3 Bil | |||
| Incyte Corp
INCY
| Kdqnbhyb | Lncxv | $13.0 Bil |
United States